Abstract Details

Title Alzheimers Care via Telemedicine for Oregon (ACT-ON), Phase I: Establishing the Reliability of Telemedicine-Based Measures

Topic Aging, Dementia, and Behavioral Neurology

Presentation(s) (-)

Poster/Presentation
Number 006

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Allison Lindauer, PhD, APRN (Oregon Health & Science University) PRESENTER	The institution of Dr. Lindauer has received research support from National Institute on Aging. The institution of Dr. Lindauer has received research support from National Institute on Aging.
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
Hiroko H. Dodge, PhD (Massachusetts General Hospital)	No disclosure on file
Jeffrey A. Kaye, MD, FAAN (Oregon Hlth Sci Univ.)	Dr. Kaye has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Kaye has stock in Life Analytics. The institution of Dr. Kaye has received research support from NIH. The institution of Dr. Kaye has received research support from NSF. The institution of Dr. Kaye has received research support from AbbVie. Dr. Kaye has received intellectual property interests from a discovery or technology relating to health care.
Deniz Erten-Lyons, MD, FAAN (FDA)	Dr. Erten-Lyons has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acadia Pharamceuticals.

��ɫ��